PlainRecalls
FDA Drug Critical Class I Ongoing

Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV, Rx Only, 60 Tablets per carton, 10 blister cards containing 6 tablets each, Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-310-02 (carton), NDC#: 49884-310-52 (blisters).

Reported: January 15, 2025 Initiated: November 18, 2024 #D-0178-2025

Product Description

Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV, Rx Only, 60 Tablets per carton, 10 blister cards containing 6 tablets each, Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-310-02 (carton), NDC#: 49884-310-52 (blisters).

Reason for Recall

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Details

Recalling Firm
Endo USA, Inc.
Units Affected
9,816 cartons
Distribution
Nationwide in the USA
Location
Malvern, PA

Frequently Asked Questions

What product was recalled?
Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV, Rx Only, 60 Tablets per carton, 10 blister cards containing 6 tablets each, Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-310-02 (carton), NDC#: 49884-310-52 (blisters).. Recalled by Endo USA, Inc.. Units affected: 9,816 cartons.
Why was this product recalled?
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 15, 2025. Severity: Critical. Recall number: D-0178-2025.